Today, NMPA Announces Johnson & Johnson's First PFA ProductVARIPULSEApproved for marketing. Currently, NMPA has approved three of the four major players in the electrophysiology field (Boston Scientific, Medtronic, Johnson & Johnson), Abbott needs to step up.With the approval of VARIPULSE, China's electrophysiology market has also entered a 3 VS 3 era (three domestic companies versus three imported ones). However, this situation will not last long, as a large number of domestic electrophysiology companies will quickly follow up. By 2025, China’s electrophysiology market will enter an era of intense competition (historically unprecedented).
Now no one can tell which PFA product will dominate the market. Although Johnson & Johnson is somewhat behind other manufacturers, the gap is not large (about a year). Given its strong distribution channels and brand influence in China, it can easily catch up. Moreover, Johnson & Johnson has a secret weapon.CARTO 3 and ICE are the foundation for Johnson & Johnson's success in the radiofrequency ablation era. Johnson & Johnson relies on...VARIPULSE+CARTO 3+ICE is likely to usher in the PFA zero-ray era, allowing doctors and patients to say goodbye to radiation exposure.Of course, Johnson & Johnson also needs to address the issues discovered in the United States, but with its strong foundation in electrophysiology, these should be resolved quickly.
VARIPULSEComposed of the VARIPULSE ablation catheter and TRUPULSE generator, and capable ofCompatible with Carto 3.VARIPULSEIs the first and only integratedCarto 3PFA Technology: Achieving an intuitive and reproducible workflow through real-time visualization and feedback mechanisms.Carto is Johnson & Johnson's greatest advantage in the PFA field to defeat other competitors in the future. Without3DStandardMeasurement System，The therapeutic effect of PFA is at least halved, while Johnson & Johnson possesses the most powerful and advanced technology globally.3DStandardMeasurement System。
VARIPULSEThe ablation catheter was developed after Johnson & Johnson's previous mapping catheter, the LASSO catheter.Continuation of LASSO Catheter Technology. This also demonstrates Johnson & Johnson's capabilities in the catheter fieldProfound Technical Reserve。
VARIPULSEThe ablation catheter has 10 electrodes on its circular tip, and the size of the circular tip is adjustable (from 25 to 35mm). MeanwhileVARIPULSEThe ablation catheter can be bidirectionally deflected, with one side deflecting 180° and the other side 90°, making it suitable for all four pulmonary veins, including the right inferior pulmonary vein. PFA is applied in a bipolar configuration between skipped electrodes (i.e., electrode 1 to electrode 3) and between each adjacent electrode pair (i.e., electrode 1-2 and 2-3) at an energy level of 1800 V. Each PFA application consists of a sequence of microsecond-long biphasic pulses across all three bipolar configurations, with a total application duration of approximately 250 milliseconds.
Biosense Webster, a professional medical device company under Johnson & Johnson, is dedicated to researching and developing electrophysiological interventional diagnosis and treatment products, providing comprehensive solutions for arrhythmia diseases to physicians and patients. Biosense is a world leader in 3D mapping systems and software with its excellent and innovative technology.It is also the inventor of the world's first curved catheter.
